About
Dr Carl Sheridan is the academic education lead for the Department of Eye and Vision Sciences at the University of Liverpool. He is an ocular cell biologist with over 30 years of research experience in eye health and disease. His work focuses on understanding cellular mechanisms that drive glaucoma and ocular wound healing.
Carl’s current research investigates the trabecular meshwork and its role in primary open-angle glaucoma (POAG). He develops advanced 3D in vitro models and organ culture systems to study disease progression. His team explores stem cell-based strategies and biomaterials to regenerate the outflow pathway and restore intraocular pressure control.
Earlier in his career, Carl pioneered research into wound healing after glaucoma surgery and retinal pigment epithelium (RPE) biology. His fellowship work helped establish cell transplantation concepts that underpin current regenerative medicine approaches. He continues to integrate tissue engineering and bioengineering into ocular research.
Carl’s ethos is rooted in a multidisciplinary team approach to solving complex research challenges. He collaborates across biomedicine, bioengineering, and clinical science to translate laboratory findings into therapies that prevent sight loss.
Carl welcomes PhD applications in glaucoma research, wound healing, tissue engineering, and regenerative medicine.
Prizes or Honours
- Dr Yamini Krishna received a “Highly Recommended" at the House of Commons (Top Younger Scientists, Engineers and Technologists (SET) ceremony at the House of Commons, 2006)
- Roy Mapstone prize (Mersey Deanary- Ophthalmology, 2001)
- Mapstone Research Workshop, Liverpool, UK (Prize, 1997)
Funded Fellowships
- International Glaucoma Association Fellowship (International Glaucoma Association, 2011)